Zealand Pharma: Funding, Investors & Team (Sep 2026)
Zealand Pharma A/S is a biotech company that specializes in developing peptides into medications. They have a growing pipeline of novel specialty drug candidates and partnerships with companies like Sanofi, Helsinn Healthcare, and Boehringer Ingelheim. Their first medicine, lixisenatide, is marketed globally as Lyxumia by Sanofi and is undergoing regulatory review in the US. Zealand also has other drugs in development, such as danegaptide and ZP1848, for various medical conditions. The company is located in Copenhagen, Denmark. For more information, visit their website or follow them on Twitter.
Zealand Pharma has raised $1.0B across 1 funding round on record, the most recent an undisclosed round of $1.0B announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zealand Pharma Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Zealand Pharma Funding Rounds
Zealand Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Zealand Pharma Funding Compared to Other Biotechnology Startups
Zealand Pharma's latest round of $1.0B is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zealand Pharma in Biotechnology and Copenhagen
Companies Similar to Zealand Pharma
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Zealand Pharma Funding FAQs
What does Zealand Pharma do?
Zealand Pharma A/S is a biotech company that specializes in developing peptides into medications. They have a growing pipeline of novel specialty drug candidates and partnerships with companies like Sanofi, Helsinn Healthcare, and Boehringer Ingelheim. Their first medicine, lixisenatide, is marketed globally as Lyxumia by Sanofi and is undergoing regulatory review in the US. Zealand also has other drugs in development, such as danegaptide and ZP1848, for various medical conditions. The company is located in Copenhagen, Denmark. For more information, visit their website or follow them on Twitter.
How much funding has Zealand Pharma raised?
Zealand Pharma has raised $1.0B across 1 round on record. The most recent is an undisclosed round of $1.0B announced in Jun 2024.
When did Zealand Pharma last raise funding?
Zealand Pharma's most recent funding round on record is an undisclosed round of $1.0B, announced in Jun 2024.
Who founded Zealand Pharma?
FundedIQ lists David Solomon (Founder) at Zealand Pharma.
Where is Zealand Pharma headquartered?
Zealand Pharma is based in Copenhagen, Hovedstaden, Denmark.
How many employees does Zealand Pharma have?
Zealand Pharma is in the 251-500 employee band.
How does Zealand Pharma's funding compare to other Biotechnology startups?
Zealand Pharma's latest round of $1.0B is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Zealand Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zealand Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.